Diagnosis and management of schistosomiasis

BMJ

Volumn 342, Issue 7807, 2011, Pages

  Gray, Darren J ^a,b   Ross, Allen G ^a   Li, Yue Sheng ^b,c   McManus, Donald P ^b  

^a GRIFFITH UNIVERSITY   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; PLACEBO; PRAZIQUANTEL; PREDNISONE;

CHRONIC DISEASE; CLINICAL FEATURE; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE TRANSMISSION; DIZZINESS; DRUG ABSORPTION; DRUG CLEARANCE; DRUG ERUPTION; DRUG METABOLISM; FIRST PASS EFFECT; GASTROINTESTINAL DISEASE; HUMAN; LABORATORY TEST; LIVER DISEASE; MORBIDITY; NAUSEA; NEUROSCHISTOSOMIASIS; NONHUMAN; PHYSICAL EXAMINATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PRURITUS; REVIEW; RISK FACTOR; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMA INTERCALATUM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; UROGENITAL TRACT DISEASE;

ACUTE DISEASE; CHRONIC DISEASE; FEMALE; GENITAL DISEASES, FEMALE; GENITAL DISEASES, MALE; HUMANS; INTESTINAL DISEASES, PARASITIC; MAGNETIC RESONANCE IMAGING; MALE; NEUROSCHISTOSOMIASIS; SCHISTOSOMIASIS; SCHISTOSOMIASIS HAEMATOBIA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84859001797     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.d2651     Document Type: Review

References (32)

1. Ross AGP, Bartley PB, Sleigh AC, Olds GR, Li Y, Williams GM, McManus DP. Schistosomiasis. N Eng J Med 2002;346:1212-9.
2. Gryseels B, Polman K, Clerinx J, Kestens L. Human schistosomiasis. Lancet 2006;368:1106-18. (Pubitemid 44402679)
3. Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J. Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis 2006;6:411-25. (Pubitemid 43949139)
4. King CH, Dickman K, Tisch DJ. Reassessment of the cost of chronic helminthic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet 2005;365:561-9.
5. King CH, Dangerfield-Cha M. The unacknowledged impact of chronic schistosomiasis. Chronic Illness 2008;4:65-79. (Pubitemid 351341878)
6. Mas-Coma S, Valero MA, Bargues MD. Climate change effects on trematodiases, with emphasis on zoonotic fascioliasis and schistosomiasis. Vet Parasitol 2009;163:264-80
7. Leshem E, Meltzer E, Marva E, Schwartz E. Travel-related schistosomiasis acquired in Laos. Emerg Infect Dis 2009;15:1823-6.
8. Ross AG, Vickers D, Olds GR, Shah SM, McManus DP. Katayama syndrome. Lancet Infect Dis 2007;7:218-24. (Pubitemid 46274518)
9. Wynn TA, Thompson RW, Cheever AW, Mentink-Kane MM. Immunopathogenesis of schistosomiasis. Immunol Rev 2004;201:156-67. (Pubitemid 39318450)
10. Burke ML, Jones MK, Gobert GN, Li YS, Ellis MK, McManus DP. Immunopathogenesis of human schistosomiasis. Parasite Immunol 2009;31:163-76.
11. Carod-Artal FJ. Neurological complications of Schistosoma infection. Trans R Soc Trop Med Hyg 2008;102:107-16.
12. Ferrari TC. Involvement of the central nervous system in the schistosomiasis. Mem Inst Oswaldo Cruz 2004;99:59-62. (Pubitemid 39278617)
13. McManus DP, Gray DJ, Li YS, Feng Z, Williams GM, Stewart D, et al. Schistosomiasis in the Peoples' Republic of China: the era of the Three Gorges Dam. Clinic Microbiol Rev 2010;23:442-66.
14. Katz N, Chaves A, Pellegrino J. A simple device for quantitative stool thick-smear technique for schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo 1972;14:397-400.
15. Oliveira LM, Santos HL, Gonçalves MM, Barreto MG, Peralta JM. Evaluation of polymerase chain reaction as an additional tool for the diagnosis of low-intensity Schistosoma mansoni infection. Diagn Microbiol Infect Dis 2010;68:416-21.
16. Wichmann D, Panning M, Quack T, Kramme S, Burchard GD, Grevelding C, Drosten C. Diagnosing schistosomiasis by detection of cell-free parasite DNA in human plasma. PLoS Negl Trop Dis 2009;3:e422.
17. Gomes LI, Dos Santos Marques LH, Enk MJ, de Oliveira MC, Coelho PM, Rabello A. Development and evaluation of a sensitive PCR-ELISA system for detection of Schistosoma infection in feces. PLoS Negl Trop Dis 2010;4:e664.
18. Ellis MK, Li Y, Hou X, Chen H, McManus DP. sTNFR-II and sICAM-1 are associated with acute disease and hepatic inflammation in schistosomiasis japonica. Int J Parasitol 2008;38:717-23. (Pubitemid 351452024)
19. Bergquist R, Johansen MV, Utzinger J. Diagnostic dilemmas in helminthology: what tools to use and when? Trends Parasitol 2009;25:151-6.
20. Chand MA, Chiodini PL, Doenhoff MJ. Development of a new assay for the diagnosis of schistosomiasis, using cercarial antigens. Trans R Soc Trop Med Hyg 2010;104:255-8.
21. Stothard JR, Sousa-Figueiredo JC, Standley C, Van Dam GJ, Knopp S, Utzinger J, et al. An evaluation of urine-CCA strip test and fingerprick blood SEA-ELISA for detection of urinary schistosomiasis in schoolchildren in Zanzibar. Acta Trop 2009;111:64-70.
22. Doenhoff MJ, Cioli D, Utzinger J. Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis. Curr Opin Infect Dis 2008;21:659-67.
23. Cioli D, Pica-Mattoccia L. Praziquantel. Parasitol Res 2003;90:S3-S9.
24. Hou XY, McManus DP, Gray DJ, Balen J, Luo XS, He YK, et al. A randomized, double-blind, placebo-controlled trial of safety and efficacy of combined praziquantel and artemether treatment for acute schistosomiasis japonica in China. Bull World Health Organ 2008;86:788-95.
25. Li Y, Sleigh AC, Williams GM, Ross AG, Forsyth SJ, Tanner M, McManus DP. Measuring exposure to Schistosoma japonicum in China. III. Activity diaries, snail and human infection, transmission ecology and options for control. Acta Trop 2000;75:279-89.
26. Sayed AA, Simeonov A, Thomas CJ, Inglese J, Austin CP, Williams DL. Identification of oxadiazoles as new drug leads for the control of schistosomiasis Nat Med 2008;14:407-12.
27. Keiser J, N'Guessan NA, Adoubryn KD, Silué KD, Vounatsou P, Hatz C, et al. Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, and praziquantel against Schistosoma haematobium : randomized, exploratory open-label trial. Clin Infect Dis 2010;50:1205-13.
28. Utzinger J, Xiao SH, Tanner M, Keiser J. Artemisinins for schistosomiasis and beyond. Curr Opin Investig Drugs 2007;8:105-16. (Pubitemid 46438464)
29. Xiao SH. Development of antischistosomal drugs in China, with particular consideration to praziquantel and the artemesinins. Acta Trop 2005;96:153-67.
30. Obonyo CO, Muok EM, Mwinzi PN. Efficacy of artesunate with sulfalene plus pyrimethamine versus praziquantel for treatment of Schistosoma mansoni in Kenyan children: an open-label randomised controlled trial. Lancet Infect Dis 2010;10:603-11.
31. Utzinger J, Tanner M, Keiser J. ACTs for schistosomiasis: do they act? Lancet Infect Dis 2010;10:579-81.
32. Gray DJ, McManus DP, Li YS, Williams GM, Bergquist R, Ross AG. Schistosomiasis elimination: lessons from the past guide the future. Lancet Infect Dis 2010;10:733-6.